Rebel Medicine
Rebel Medicine is a science-led pharmaceutical company dedicated to revolutionizing acute pain management by developing innovative, non-opioid solutions. Their mission is to create impactful products that improve patient outcomes and reduce healthcare costs. By leveraging novel drug delivery technologies, Rebel Medicine aims to provide effective pain management solutions that eliminate the need for opioids, thus addressing a significant unmet medical need in acute and postoperative pain management.
Rebel Medicine
48 S Rio Grande Street, Salt Lake City, UT 84101
What We Do
Alevatrix™ is an injectable long-acting formulation of the local anesthetic, bupivacaine, designed to enable opioid-free management of postoperative pain. It is based on Rebel Medicine’s proprietary injectable gel technology and is packaged in a ready-to-use, prefilled syringe for both regional and local anesthesia.
ALX-UL is an ultra long-acting injectable formulation of bupivacaine that extends analgesia to 7 days for the treatment of postoperative pain, leveraging Rebel Medicine’s proprietary injectable drug delivery technology.
RBL-001 is an extended-release solution of bupivacaine for local or regional anesthesia or analgesia for various surgical and therapeutic procedures, designed to deliver quick onset and 36-48 hours of analgesic duration.
Alevaderm™ is a long-acting analgesic wound dressing under development to provide 7 days of pain relief and protection to painful dermal injuries, combining moist wound healing with prolonged analgesia.
Application Area
Show LessBattlefield Resuscitation
Key People
News & Updates
Rebel Medicine has successfully completed a Pre-IND meeting for their lead asset, Alevatrix™, marking a significant milestone in its development.
The company has published data from pre-clinical studies of Alevatrix™ in large animals, demonstrating its efficacy in pain management.
Rebel Medicine has been awarded significant grants from NSF and NIH to further their research and development efforts.